CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...